Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Quintiles Transitional Holdings (Q)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Quintiles Transitional Holdings 4820 EMPEROR BLVD. DURHAM NC 27703 USA

P: 919-998-2000

Description:

Quintiles Transnational Holdings Inc. provides professional services, information and partnering solutions to the pharmaceutical services, biotechnology and healthcare industries. The Company has two segments: Product Development and Integrated Healthcare Services. It offers project management, clinical monitoring services, strategic planning and design services, consulting services contract sales, market entry/market exit, integrated channel management, patient engagement, market access and commercialization consulting, brand and scientific communication, and medical education services; outcome/observational services. The Company operates in Americas, Europe and Africa, and the Asia-Pacific. Quintiles Transnational Holdings Inc. is based in Durham, North Carolina.

Key Statistics

Overview:

Market Capitalization, $K 21,866,360
Shares Outstanding, K 211,310
Annual Sales, $ 6,878 M
Annual Net Income, $ 115,000 K
Last Quarter Sales, $ 2,465 M
Last Quarter Net Income, $ 84,000 K
60-Month Beta 0.65
% of Insider Shareholders 6.40%
% of Institutional Shareholders 94.04%

Growth:

1-Year Return 34.58%
3-Year Return 78.85%
5-Year Return 0.00%
5-Year Revenue Growth 58.93%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.19 on 10/26/17
Next Earnings Date N/A
Earnings Per Share ttm 4.38
EPS Growth vs. Prev Qtr 9.17%
EPS Growth vs. Prev Year 19.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

Q Ratios

Ratio
Price/Earnings ttm 23.50
Price/Earnings forward 22.39
Price/Earnings to Growth 1.70
Return-on-Equity (After Tax) 12.60
Return-on-Assets (Before Tax) 4.65
Profit Margin % 1.67
Net Margin % N/A
Debt/Equity 1.14
Price/Sales 3.16
Price/Cash Flow N/A
Price/Book 2.91
Book Value/Share 35.53
Interest Coverage 1.91
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar